Stock de sistemas delcath
Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Reverse Stock Split reported on October 21, 2019 will be postponed per a subsequent notification received from FINRA after-market that they have decided to continue their review. 10/18/2019 · NEW YORK, Oct. 18, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company’s Board of Directors has authorized a reverse stock split of the Company’s common stock at a ratio of 1-for-100. Beginning with the October 22, 2019 trading date, Delcath’s shares will be designated by the symbol DCTHD for 20 trading days, and thereafter will revert to the symbol DCTH. The new CUSIP number for the common stock following the reverse stock split will be 24661P 807. 10/22/2019 · NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. , an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Reverse Stock Split reported on October 21, 2019 will be postponed per a subsequent notification received from FINRA after-market that they have decided to Back to DCTH Stock Lookup. 2019 08:00 AM Delcath Systems Announces Presentation at the Rodman & Renshaw 21st Annual Global Investment Conference sponsored by H.C 10/22/2019 · NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Reverse Stock Split reported on October 21, 2019 will be postponed per a subsequent notification received from FINRA after-market that they have
10/22/2019 · NEW YORK, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Reverse Stock Split reported on October 21, 2019 will be postponed per a subsequent notification received from FINRA after-market that they have
10/18/2019 · NEW YORK, Oct 18, 2019 (GLOBE NEWSWIRE via COMTEX) -- Delcath Systems, Inc. (otcqb:DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces that the Company's Board of Directors has authorized a reverse stock split of the Company's common stock at a ratio of 1-for-100. Real-time trade and investing ideas on Delcath Systems, Inc. DCTH from the largest community of traders and investors. Rooms Trade App. ©2019 StockTwits, Inc. Delcath Systems, Inc. stock quote and DCTH charts. Latest stock price today and the US's most active stock market forums. 9/6/2017 · Delcath CEO Dr. Jennifer Simpson has once again written a letter to shareholders asking for a vote in favor of a reverse split. The company has yet to announce the split ratio (could range from 1-for-20 to 1-for-500). The deadline for voting is September 6, 2017, before 11:59 p.m. EST. Delcath Systems Securities Delcath Systems securities originally came on the market on June 16, 2000 with an IPO offering of 1.2m shares priced at $6.00 per share. Securities were listed on both the NASDAQ and Boston Stock Exchange. 12/3/2019 · Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that the Company’s Board of Directors has authorized a 1-for-700 reverse stock split of the Company’s common stock. Delcath Systems, Inc. (DCTH) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.
Delcath Systems Stock Price Forecast, DCTH stock price prediction. Price target in 14 days: 54.906 USD. The best long-term & short-term Delcath Systems share price
: Get the latest Delcath Systems stock price and detailed information including news, historical charts and realtime prices. 4/10/2014 · S hares of Delcath Systems, Inc. ( DCTH) tanked nearly 20% to $3.73 following its 1-to-16 reverse stock split, which came into effect yesterday. According to an SEC filing, the stock split trimmed Delcath shares to roughly 9.4 million from 150.9 million. 12/6/2019 · View today's stock price, news and analysis for Delcath Systems Inc. (DCTH). Barron's also provides information on historical stock ratings, target prices Find real-time DCTHD - Delcath Systems Inc stock quotes, company profile, news and forecasts from CNN Business. Delcath Systems, Inc. Delcath Systems, Inc. (NASDAQ: DCTH) is a publicly traded specialty pharmaceutical and medical device company that develops percutaneous perfusion technologies for the targeted administration of high-dose chemotherapeutic agents to specific organs or regions of the body.
DCTH - Delcath Systems Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com.
12/13/2019 · The following slide deck was published by Delcath Systems, Inc. in conjunction with this event. Download PDF 119 Click to enlarge Notes 3/11/2013 · Real time Delcath Systems (DCTH) stock price quote, stock graph, news & analysis. 6/12/2017 · Delcath Systems, Inc. (NASDAQ: DCTH) is having an incredibly strong start to the trading session today as investor excitement consumes the stock. The excitement surrounds the company’s coming data release, which could happen as soon as this month. Delcath Systems Stock Price Forecast, DCTH stock price prediction. Price target in 14 days: 54.906 USD. The best long-term & short-term Delcath Systems share price Delcath Systems Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Delcath are investigating the potential for our therapy in two key areas: 1. FOCUS 301A Registration study—for patients with ocular melanoma metastatic to the liver.
Delcath Systems, Inc. chart and DCTH price. Free real-time prices, trades and chat. Delcath Systems, Inc. (DCTH) stock price, charts, trades & the US's most popular discussion forums.
9/6/2017 · Delcath CEO Dr. Jennifer Simpson has once again written a letter to shareholders asking for a vote in favor of a reverse split. The company has yet to announce the split ratio (could range from 1-for-20 to 1-for-500). The deadline for voting is September 6, 2017, before 11:59 p.m. EST. Delcath Systems Securities Delcath Systems securities originally came on the market on June 16, 2000 with an IPO offering of 1.2m shares priced at $6.00 per share. Securities were listed on both the NASDAQ and Boston Stock Exchange. 12/3/2019 · Delcath Systems, Inc. (DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced that the Company’s Board of Directors has authorized a 1-for-700 reverse stock split of the Company’s common stock. Delcath Systems, Inc. (DCTH) stock price, charts, trades & the US's most popular discussion forums. Free forex prices, toplists, indices and lots more.
DCTH - Delcath Systems Inc. Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Delcath Systems Inc Weekly Stock Prices Chart. This stock price chart for Delcath Systems Inc, symbol DCTH, Nasdaq Stock Exchange is updated weekly. TradingCharts.com offers over 30 thousand free stock price charts and stock market quotes. DCTH: Get the latest Delcath Systems stock price and detailed information including DCTH news, historical charts and realtime prices. Delcath Systems, Inc. chart and DCTH price. Free real-time prices, trades and chat. Delcath Systems, Inc. (DCTH) stock price, charts, trades & the US's most popular discussion forums. At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. Reddit is not like StockTwits. When submitting a post here, try to make sure it is informative and/or will possibly result in a discussion. Questions are allowed, but please make sure you have at least done a google search beforehand. Stock charts are allowed, but make sure you describe it.